Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.11 | 2.26 |
NAV | ₹12.66 | ₹170.33 |
Fund Started | 07 Oct 2024 | 13 Oct 2005 |
Fund Size | ₹390.19 Cr | ₹1420.55 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 15.54% | 6.59% |
3 Year | - | 18.78% |
5 Year | - | 21.35% |
1 Year
3 Year
5 Year
Equity | 100.49% | 96.69% |
Cash | -0.49% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
BSE Ltd. | 22.68% |
HDFC Asset Management Company Ltd. | 15.22% |
Multi Commodity Exchange Of India Ltd. | 13.13% |
Central Depository Services (India) Ltd. | 7.87% |
360 One Wam Ltd. | 6.94% |
Computer Age Management Services Ltd. | 5.27% |
Angel One Ltd. | 4.46% |
Nippon Life India Asset Management Ltd. | 4.30% |
Motilal Oswal Financial Services Ltd. | 4.20% |
KFin Technologies Ltd. | 4.07% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Kapil Menon | Sri Sharma |
Start Date | 02 Jun 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide returns, before expenses, that commensurate with the performance of Nifty Capital Markets Index (TRI), subject to tracking error. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 07 Oct 2024 | 13 Oct 2005 |
Description
Launch Date